Your browser doesn't support javascript.
loading
Predicting post-liver transplant outcomes in patients with acute-on-chronic liver failure using Expert-Augmented Machine Learning.
Ge, Jin; Digitale, Jean C; Fenton, Cynthia; McCulloch, Charles E; Lai, Jennifer C; Pletcher, Mark J; Gennatas, Efstathios D.
Afiliação
  • Ge J; Division of Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA. Electronic address: jin.ge@ucsf.edu.
  • Digitale JC; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.
  • Fenton C; Division of Hospital Medicine, Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
  • McCulloch CE; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.
  • Lai JC; Division of Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
  • Pletcher MJ; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.
  • Gennatas ED; Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.
Am J Transplant ; 23(12): 1908-1921, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37652176
ABSTRACT
Liver transplantation (LT) is a treatment for acute-on-chronic liver failure (ACLF), but high post-LT mortality has been reported. Existing post-LT models in ACLF have been limited. We developed an Expert-Augmented Machine Learning (EAML) model to predict post-LT outcomes. We identified ACLF patients who underwent LT in the University of California Health Data Warehouse. We applied the RuleFit machine learning (ML) algorithm to extract rules from decision trees and create intermediate models. We asked human experts to rate the rules generated by RuleFit and incorporated these ratings to generate final EAML models. We identified 1384 ACLF patients. For death at 1 year, areas under the receiver-operating characteristic curve were 0.707 (confidence interval [CI] 0.625-0.793) for EAML and 0.719 (CI 0.640-0.800) for RuleFit. For death at 90 days, areas under the receiver-operating characteristic curve were 0.678 (CI 0.581-0.776) for EAML and 0.707 (CI 0.615-0.800) for RuleFit. In pairwise comparisons, both EAML and RuleFit models outperformed cross-sectional models. Significant discrepancies between experts and ML occurred in rankings of biomarkers used in clinical practice. EAML may serve as a method for ML-guided hypothesis generation in further ACLF research.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Insuficiência Hepática Crônica Agudizada Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Insuficiência Hepática Crônica Agudizada Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2023 Tipo de documento: Article